Natural polysaccharides platforms for oral controlled release of ketoprofen lysine salt

被引:13
|
作者
Cerciello, Andrea [1 ,2 ]
Auriemma, Giulia [1 ]
Del Gaudio, Pasquale [1 ]
Cantarini, Marco [3 ]
Aquino, Rita P. [1 ]
机构
[1] Univ Salerno, Dept Pharm, Via Giovanni Paolo 2 132, I-84084 Fisciano, SA, Italy
[2] Univ Salerno, PhD Program Drug Discovery & Dev, Fisciano, SA, Italy
[3] Dompe Farmaceut SPA, R&D Dept, Laquila, Italy
关键词
Ketoprofen lysine salt; oral controlled release platforms; polysaccharides based beads; prilling; xerogel; DRUG-DELIVERY; ALGINATE BEADS; HYDROGEL BEADS; PECTIN; FORMULATIONS; DESIGN; EFFICACY;
D O I
10.1080/03639045.2016.1195401
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Context: Ketoprofen lysinate (KL) is one of the most widely used non-steroidal anti-inflammatory drugs in the symptomatic treatment of some chronic inflammatory diseases. Compared to ketoprofen, KL shows better pharmacokinetics and tolerability. However, due to its short half-life of 1-2h, a multiple dose regimen is required for oral administration. Thus, the present work deals with its encapsulation in a hydrogel-based system by prilling in order to prolong its activity.Objective: In this paper, we propose alginate and pectin as carriers and release tailoring agent for the development of hydrogel-based beads for KL retarded and sustained release.Materials and methods: Beads were produced by a Nisco Encapsulator (R) using alginate or pectin. Operative variables were optimized to produce beads with desired morphology and size. Solid state properties were analyzed by SEM and DSC. Drug release performance was studied by Pharmacopeia pH-change assay to simulate gastrointestinal environment.Results and discussion: Prilling technique was successfully used to encapsulate high soluble drugs as KL in polysaccharides-based hydrogels. Pectin proved to be a proper polymer able to encapsulate ketoprofen lysine salt. Formulation (F8) showed good morphological properties and size, high drug content (15.6%) and encapsulation efficiency (93.5%) and promising drug release profiles. Hosting F8 in an acid-resistant capsule (DR((R))caps) a delivery platform has been developed to control KL release in a delayed (90min lag time) and prolonged way (270min complete release).Conclusion: The platform may be proposed as potentially useful in the oral administration of NSAIDs in chronic inflammatory diseases affected by circadian rhythm.
引用
收藏
页码:2063 / 2069
页数:7
相关论文
共 50 条
  • [1] Possible Immunomodulating Effect Ketoprofen and Ketoprofen Lysine Salt on the Brain
    Nieradko-Iwanicka, Barbara
    Ruszel, Kinga
    Herbet, Mariola
    Pawlowski, Kamil
    POLISH HYPERBARIC RESEARCH, 2024, 88 (03) : 87 - 93
  • [2] DEVELOPMENT OF CONTROLLED-RELEASE FORMULATIONS OF KETOPROFEN FOR ORAL USE
    HABIB, MJ
    MESUE, R
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (12) : 1463 - 1472
  • [3] Intramuscular bioavailability of ketoprofen lysine salt in horses
    Anfossi, P
    Villa, R
    Montesissa, C
    Carli, S
    VETERINARY QUARTERLY, 1997, 19 (02) : 65 - 68
  • [4] An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen
    Vergote, GJ
    Vervaet, C
    Van Driessche, I
    Hoste, S
    De Smedt, S
    Demeester, J
    Jain, RA
    Ruddy, S
    Remon, JP
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 219 (1-2) : 81 - 87
  • [5] Natural polysaccharides for controlled delivery of oral therapeutics: a recent update
    Layek, Buddhadev
    Mandal, Sanchita
    CARBOHYDRATE POLYMERS, 2020, 230
  • [6] Encapsulation of Ketoprofen and Ketoprofen Lysinate by Prilling for Controlled Drug Release
    Pasquale Del Gaudio
    Paola Russo
    Maria Rosaria Lauro
    Paolo Colombo
    Rita P. Aquino
    AAPS PharmSciTech, 2009, 10 : 1178 - 1185
  • [7] Encapsulation of Ketoprofen and Ketoprofen Lysinate by Prilling for Controlled Drug Release
    Del Gaudio, Pasquale
    Russo, Paola
    Lauro, Maria Rosaria
    Colombo, Paolo
    Aquino, Rita P.
    AAPS PHARMSCITECH, 2009, 10 (04): : 1178 - 1185
  • [8] Encapsulation of ketoprofen for controlled drug release
    Arida, Adi I.
    Al-Tabakha, Moawia M.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 66 (01) : 48 - 54
  • [9] Unexpected Salt/Cocrystal Polymorphism of the Ketoprofen-Lysine System: Discovery of a New Ketoprofen-l-Lysine Salt Polymorph with Different Physicochemical and Pharmacokinetic Properties
    Aramini, Andrea
    Bianchini, Gianluca
    Lillini, Samuele
    Bordignon, Simone
    Tomassetti, Mara
    Novelli, Rubina
    Mattioli, Simone
    Lvova, Larisa
    Paolesse, Roberto
    Chierotti, Michele Remo
    Allegretti, Marcello
    PHARMACEUTICALS, 2021, 14 (06)
  • [10] In Vitro Release Pattern of Controlled Release Ketoprofen Tablets
    Zafar, Farya
    Shoaib, Muhammad H.
    Ali, Huma
    Naveed, Safila
    Baloch, Saba Ajaz
    Siddiqui, Shehla
    Fatima, Rasheeda
    LATIN AMERICAN JOURNAL OF PHARMACY, 2015, 34 (07): : 1283 - 1292